HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Head And Neck Cancers

Head And Neck Cancers

In the realm of cancer research, head and neck cancers present a complex challenge due to their diverse origins and intricate anatomical structures. These malignancies encompass tumors in the oral cavity, throat, larynx, and adjacent regions. Recent advancements in understanding the molecular mechanisms driving these cancers have spurred innovative therapeutic approaches. Targeted therapies and immunotherapies are emerging as promising avenues, aiming to combat specific genetic mutations and harness the body's immune system to fight cancer cells. Additionally, precision medicine techniques enable tailored treatment strategies, optimizing outcomes while minimizing side effects. Furthermore, multidisciplinary collaborations among oncologists, surgeons, geneticists, and researchers are fostering comprehensive care paradigms for patients. Through relentless exploration and collaboration, the landscape of head and neck cancer research continues to evolve, offering hope for improved diagnostics, treatments, and ultimately, patient survival and quality of life.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp